Michal Fisher
IP Consultant @ Accelmed
Michal Fisher is a startup investor at Accelmed. Dr. Fisher is a partner at Webb & Associates Patent Attorneys, a worldwide intellectual property company. She has more than 15 years' of cumulative academic and business experience in the life science and medical device fields.Dr. Fisher currently focuses on patent drafting and prosecution, opinion work, including infringement,patentability, validity, and freedom to operate, as well as due diligence and strategic management of intellectual property portfolios for companies.Dr. Fisher graduated Cum Laude with a bachelor's degree in chemistry from Tel Aviv University and a master's and doctorate in chemistry from the Technion-Israel Institute of Technology, Haifa, Israel.
Last updated:
For AI agents: llms.txt
About Accelmed
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Accelmed Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Gilad Rotem
Medical Analyst
|
|||
Lior Shav
Private Equity Investment Manager
|
|||
|
Michal Fisher
IP Consultant
|
|||
Uri Geiger
Founder & Managing Partner
|
|||
Camilo Rico
Vice President
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
